Faron Pharmaceuticals
Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland. The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer. It specialises in the development of treatments for acute organ traumas, vascular damage and cancer immunotherapy. In 2020 was selected to take part in the WHO Solidarity trial and trials to find drugs for the symptoms of Covid_19. In June 2020, Faron received a €2,100,000 low interest rate loan from Business Finland for Traumakine manufacturing.
Link from a Wikipage to another Wikipage
primaryTopic
Faron Pharmaceuticals
Faron Pharmaceuticals is a Finnish drug discovery and development company based in Turku, Finland. The company was founded in 2003 by a group led by Markku Jalkanen, who now acts as the company's Chief Executive Officer. It specialises in the development of treatments for acute organ traumas, vascular damage and cancer immunotherapy. In 2020 was selected to take part in the WHO Solidarity trial and trials to find drugs for the symptoms of Covid_19. In June 2020, Faron received a €2,100,000 low interest rate loan from Business Finland for Traumakine manufacturing.
has abstract
Faron Pharmaceuticals is a Fin ...... for Scandinavian shareholders.
@en
founded by
founding year
industry
key person
location
product
type
Link from a Wikipage to an external page
Wikipage page ID
62,520,612
page length (characters) of wiki page
Wikipage revision ID
989,573,668
Link from a Wikipage to another Wikipage
foundation
founder
Markku Jalkanen and others
@en
homepage
industry
key people
(CEO)
@en
Markku Jalkanen
@en
Location
Turku, Finland
@en
name
Faron Pharmaceuticals
@en
products
Traumakine, Clevegen
@en
type
wikiPageUsesTemplate
comment
Faron Pharmaceuticals is a Fin ...... for Traumakine manufacturing.
@en
label
Faron Pharmaceuticals
@en
sameAs
wasDerivedFrom
homepage
isPrimaryTopicOf
name
Faron Pharmaceuticals
@en